|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.270 HKD | -0.41% |
|
-0.55% | +0.97% |
| 02-27 | Mega Genomics Resumes Trading on Hong Kong Bourse | MT |
| 02-05 | Mega Genomics Books Lower Profit in H1 2025 | MT |
| Capitalization | 1.51B 1.71B 218M 190M 172M 164M 299M 20.17B 310M 2.05B 813M 9.65B 820M 802M 34.8B | P/E ratio 2023 |
65.9x | P/E ratio 2024 | 47.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.05B 1.19B 152M 132M 120M 114M 208M 14.02B 216M 1.42B 566M 6.71B 570M 558M 24.2B | EV / Sales 2023 |
11.5x | EV / Sales 2024 | 11.5x |
| Free-Float |
57.59% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -0.41% | ||
| 1 week | -0.55% | ||
| Current month | -0.27% | ||
| 1 month | +0.97% | ||
| 3 months | +0.97% | ||
| 6 months | +0.97% | ||
| Current year | +0.97% |
| 1 week | 6.19 |  | 7.3 |
| 1 month | 6.19 | | 7.53 |
| Current year | 6.19 | | 7.53 |
| 1 year | 5.98 | | 8.33 |
| 3 years | 5.98 | | 12.4 |
| 5 years | 5.98 | | 21 |
| 10 years | 5.98 | | 21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Jiang
CEO | Chief Executive Officer | 46 | 16/01/2024 |
Xiang Yi
CTO | Chief Tech/Sci/R&D Officer | 46 | - |
Xia An
COO | Chief Operating Officer | 43 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rong Yu
BRD | Director/Board Member | 54 | 21/04/2021 |
Mei Ling Guo
BRD | Director/Board Member | 57 | 05/08/2021 |
Lin Lin
CHM | Chairman | 50 | 21/04/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | -0.55% | +0.69% | -31.93% | 208M | |
| +5.23% | -3.67% | +33.37% | +239.13% | 28.02B | |
| -1.10% | -5.52% | -19.04% | -38.84% | 7.29B | |
| +3.24% | +2.84% | +37.73% | +168.31% | 4.97B | |
| -0.40% | -3.13% | +4.99% | +46.04% | 2.43B | |
| -2.15% | -19.47% | -22.71% | +551.15% | 2.23B | |
| +0.43% | -0.74% | -22.38% | -64.79% | 1.88B | |
| -0.79% | -4.34% | +15.17% | -21.60% | 1.78B | |
| -5.59% | -2.32% | +34.63% | +10.02% | 1.61B | |
| +0.90% | -1.82% | +13.77% | +14.62% | 1.08B | |
| Average | -0.07% | -3.87% | +7.62% | +87.21% | 5.15B | |
| Weighted average by Cap. | +2.72% | -3.68% | +19.44% | +164.27% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 151M 172M 21.94M 19.11M 17.3M 16.51M 30.03M 2.03B 31.14M 206M 81.71M 969M 82.34M 80.6M 3.5B | 164M 186M 23.82M 20.74M 18.78M 17.92M 32.6M 2.2B 33.8M 223M 88.69M 1.05B 89.38M 87.49M 3.79B |
| Net income | 30.04M 34.11M 4.36M 3.79M 3.44M 3.28M 5.96M 402M 6.18M 40.82M 16.22M 192M 16.35M 16M 694M | 45.04M 51.15M 6.53M 5.69M 5.15M 4.91M 8.94M 603M 9.27M 61.22M 24.33M 289M 24.52M 24M 1.04B |
| Net Debt | -478M -542M -69.28M -60.34M -54.64M -52.12M -94.82M -6.4B -98.31M -649M -258M -3.06B -260M -254M -11.04B | -459M -521M -66.53M -57.95M -52.47M -50.06M -91.05M -6.14B -94.41M -623M -248M -2.94B -250M -244M -10.6B |
Employees
203
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/03/26 | 7.270 $ | -0.41% | 2,800 |
| 13/03/26 | 7.300 $ | +4.29% | 1,200 |
| 12/03/26 | 7.000 $ | 0.00% | 600 |
| 11/03/26 | 7.000 $ | +4.48% | 9,400 |
| 10/03/26 | 6.700 $ | -8.34% | 800 |
- Stock Market
- Equities
- 6667 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition